  See all
 |
Articles: Myeloproliferative Dz |
Prior Articles
The efficacy of percutaneous vertebroplasty for vertebral metastases associated with solid malignancies
European Journal of Cancer, 05/29/09
Presentation of familial Mediterranean fever in a heterozygous MEFV mutation triggered by immunosuppressive therapy for myelodysplastic syndrome
International Journal of Hematology, 05/28/09 Myelodysplastic syndromes: classification and prognostic scoring systems and their applicability in Indian scenario-experience from a tertiary care center
Hematology, 05/28/09 Managing Iron Overload in Patients with Myelodysplastic Syndromes with Oral Deferasirox Therapy
The Oncologist, 05/27/09 Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial
Journal of Clinical Oncology, 05/20/09 Angiogenesis and vascular endothelial growth factor-/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2-V617F mutational status
British Journal of Haematology, 05/20/09 A minimally invasive surgical treatment possibility of osteolytic vertebral collapse in multiple myeloma
European Spine Journal, 05/19/09 Prospect of JAK2 inhibitor therapy in myeloproliferative neoplasms
Expert Review of Anticancer Therapy, 05/19/09 1p21 deletions are strongly associated with 1q21 gains and are an independent adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma
Bone Marrow Transplantation, 05/19/09 Phase I-IIa multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra(R), TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome
Journal of Hematology & Oncology, 05/15/09
Free full text
F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma
Blood, 05/15/09 Cryptic deletion of EGR1 in association with a novel balanced t(5;22)(q31;q11.2) in a patient with myelodysplastic syndrome
Cancer Genetics and Cytogenetics, 05/15/09 Kinase drug discovery approaches in chronic myeloproliferative disorders
Oncogene, 05/14/09 Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category
Annals of Hematology, 05/13/09 International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
Leukemia, 05/13/09 Bone marrow cells from patients with Shwachman-Diamond syndrome abnormally express genes involved in ribosome biogenesis and RNA processing
British Journal of Haematology, 05/12/09 Thalidomide treatment down-regulates SDF-1alpha and CXCR4 expression in multiple myeloma patients
Leukemia Research, 05/12/09 Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
Blood, 05/11/09
Evidence Based Medicine
Advances in Understanding and Management of Myeloproliferative Neoplasms
CA-A Cancer Journal for Clinicians, 05/07/09
Free full text
A frequent target of paraproteins in the sera of patients with multiple myeloma and MGUS
International Journal of Cancer, 05/05/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
188 Available Pages
|
|
